A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, Umbilical Cord Blood-derived, Stem and Progenitor Cells, versus Unmanipulated Umbilical Cord Blood for Patients with Hematological Malignancies

IRB/UVA Tracking #
20915
Contact
Contact Phone
Phase
III
Primary purpose
Treatment
Cancer PI
Leonid Volodin
Status
OPEN TO ACCRUAL
Ages
Adult